<code id='74333DAA93'></code><style id='74333DAA93'></style>
    • <acronym id='74333DAA93'></acronym>
      <center id='74333DAA93'><center id='74333DAA93'><tfoot id='74333DAA93'></tfoot></center><abbr id='74333DAA93'><dir id='74333DAA93'><tfoot id='74333DAA93'></tfoot><noframes id='74333DAA93'>

    • <optgroup id='74333DAA93'><strike id='74333DAA93'><sup id='74333DAA93'></sup></strike><code id='74333DAA93'></code></optgroup>
        1. <b id='74333DAA93'><label id='74333DAA93'><select id='74333DAA93'><dt id='74333DAA93'><span id='74333DAA93'></span></dt></select></label></b><u id='74333DAA93'></u>
          <i id='74333DAA93'><strike id='74333DAA93'><tt id='74333DAA93'><pre id='74333DAA93'></pre></tt></strike></i>

          hotspot

          hotspot

          author:knowledge    Page View:25594
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more
          Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank
          Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo

          read more
          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more

          Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo